Matches in SemOpenAlex for { <https://semopenalex.org/work/W4244585987> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4244585987 endingPage "5005" @default.
- W4244585987 startingPage "5005" @default.
- W4244585987 abstract "5005 Background: The TAX-327 study compared 3 weekly docetaxel (D3), weekly docetaxel (D1) or mitoxantrone (M), each with prednisone (P) for 1006 patients (pts) with metastatic hormone resistant prostate cancer (mHRPC). The original analysis, undertaken in August 2003 when 557 deaths had occurred, showed significantly better survival and response rates for pain, PSA and quality of life for D3 when compared with M (Tannock et al, NEJM 2004;351:1502–12). Here we present the updated survival analysis. Methods: Investigators were asked to provide date of death or last follow up for all patients alive in August 2003. Results: By December 2007 data on 276 additional deaths were obtained (total 833 deaths, see Table ). The survival benefit of D3 as compared with M has persisted with extended follow up while D1 continues to show no significant survival advantage. More patients (17.9% and 16.7%) survived =3 years in the D3 and D1 arms compared to M (13.7%). Similar trends in survival between treatment arms were seen for pts above and below 65 years of age, for those with and without pain at baseline, and for those with baseline PSA above and below median value of 115ng/ml. Conclusions: The present analysis confirms previous findings that survival is significantly longer with D3 than with M. Survival update is ongoing. [Table: see text] No significant financial relationships to disclose." @default.
- W4244585987 created "2022-05-12" @default.
- W4244585987 creator A5005542228 @default.
- W4244585987 creator A5073341676 @default.
- W4244585987 creator A5081519723 @default.
- W4244585987 creator A5084830130 @default.
- W4244585987 creator A5087929642 @default.
- W4244585987 date "2007-06-20" @default.
- W4244585987 modified "2023-09-23" @default.
- W4244585987 title "Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival of the TAX 327 study" @default.
- W4244585987 doi "https://doi.org/10.1200/jco.2007.25.18_suppl.5005" @default.
- W4244585987 hasPublicationYear "2007" @default.
- W4244585987 type Work @default.
- W4244585987 citedByCount "5" @default.
- W4244585987 countsByYear W42445859872013 @default.
- W4244585987 crossrefType "journal-article" @default.
- W4244585987 hasAuthorship W4244585987A5005542228 @default.
- W4244585987 hasAuthorship W4244585987A5073341676 @default.
- W4244585987 hasAuthorship W4244585987A5081519723 @default.
- W4244585987 hasAuthorship W4244585987A5084830130 @default.
- W4244585987 hasAuthorship W4244585987A5087929642 @default.
- W4244585987 hasConcept C10515644 @default.
- W4244585987 hasConcept C121608353 @default.
- W4244585987 hasConcept C126322002 @default.
- W4244585987 hasConcept C143998085 @default.
- W4244585987 hasConcept C2776551883 @default.
- W4244585987 hasConcept C2776694085 @default.
- W4244585987 hasConcept C2778720950 @default.
- W4244585987 hasConcept C2780192828 @default.
- W4244585987 hasConcept C2780923524 @default.
- W4244585987 hasConcept C2781190966 @default.
- W4244585987 hasConcept C3019894029 @default.
- W4244585987 hasConcept C61367390 @default.
- W4244585987 hasConcept C71924100 @default.
- W4244585987 hasConceptScore W4244585987C10515644 @default.
- W4244585987 hasConceptScore W4244585987C121608353 @default.
- W4244585987 hasConceptScore W4244585987C126322002 @default.
- W4244585987 hasConceptScore W4244585987C143998085 @default.
- W4244585987 hasConceptScore W4244585987C2776551883 @default.
- W4244585987 hasConceptScore W4244585987C2776694085 @default.
- W4244585987 hasConceptScore W4244585987C2778720950 @default.
- W4244585987 hasConceptScore W4244585987C2780192828 @default.
- W4244585987 hasConceptScore W4244585987C2780923524 @default.
- W4244585987 hasConceptScore W4244585987C2781190966 @default.
- W4244585987 hasConceptScore W4244585987C3019894029 @default.
- W4244585987 hasConceptScore W4244585987C61367390 @default.
- W4244585987 hasConceptScore W4244585987C71924100 @default.
- W4244585987 hasIssue "18_suppl" @default.
- W4244585987 hasLocation W42445859871 @default.
- W4244585987 hasOpenAccess W4244585987 @default.
- W4244585987 hasPrimaryLocation W42445859871 @default.
- W4244585987 hasRelatedWork W122177069 @default.
- W4244585987 hasRelatedWork W2005132319 @default.
- W4244585987 hasRelatedWork W2010765098 @default.
- W4244585987 hasRelatedWork W2060708716 @default.
- W4244585987 hasRelatedWork W2135620818 @default.
- W4244585987 hasRelatedWork W2568045406 @default.
- W4244585987 hasRelatedWork W2770702948 @default.
- W4244585987 hasRelatedWork W2982156914 @default.
- W4244585987 hasRelatedWork W3132581442 @default.
- W4244585987 hasRelatedWork W4229076799 @default.
- W4244585987 hasVolume "25" @default.
- W4244585987 isParatext "false" @default.
- W4244585987 isRetracted "false" @default.
- W4244585987 workType "article" @default.